BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29745092)

  • 21. Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone.
    Zhang RZ; Ma TX; Qi DW; Zhao M; Hu T; Zhang GC
    Orthop Surg; 2019 Dec; 11(6):1101-1108. PubMed ID: 31762217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of denosumab on pain and analgesic use in giant cell tumor of bone: interim results from a phase II study.
    Martin-Broto J; Cleeland CS; Glare PA; Engellau J; Skubitz KM; Blum RH; Ganjoo KN; Staddon A; Dominkus M; Feng A; Qian Y; Braun A; Jacobs I; Chung K; Atchison C
    Acta Oncol; 2014 Sep; 53(9):1173-9. PubMed ID: 24834795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study.
    Chawla S; Henshaw R; Seeger L; Choy E; Blay JY; Ferrari S; Kroep J; Grimer R; Reichardt P; Rutkowski P; Schuetze S; Skubitz K; Staddon A; Thomas D; Qian Y; Jacobs I
    Lancet Oncol; 2013 Aug; 14(9):901-8. PubMed ID: 23867211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Denosumab in patients with giant-cell tumor of bone in Norway: results from a nationwide cohort.
    Boye K; Jebsen NL; Zaikova O; Knobel H; Løndalen AM; Trovik CS; Monge OR; Hall KS
    Acta Oncol; 2017 Mar; 56(3):479-483. PubMed ID: 28105885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
    Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
    Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone.
    Traub F; Singh J; Dickson BC; Leung S; Mohankumar R; Blackstein ME; Razak AR; Griffin AM; Ferguson PC; Wunder JS
    Eur J Cancer; 2016 May; 59():1-12. PubMed ID: 26990281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone.
    Lau CP; Huang L; Wong KC; Kumta SM
    Connect Tissue Res; 2013; 54(6):439-49. PubMed ID: 24060052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors.
    Yamagishi T; Kawashima H; Ogose A; Ariizumi T; Sasaki T; Hatano H; Hotta T; Endo N
    PLoS One; 2016; 11(5):e0154680. PubMed ID: 27163152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of denosumab in treatment of unresectable spine and sacrum giant cell tumor of bone.
    Arefpour A; Shafieesabet M; Chehrassan M; Ahmadzadehnanva A; Ghandhari H
    Musculoskelet Surg; 2024 Mar; 108(1):93-98. PubMed ID: 37940782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histopathological response to denosumab in giant cell tumours of bone - A review of 11 cases.
    Kumar R; Mallya V; Mandal S; Tomar R; Khurana N; Maini L
    J Cancer Res Ther; 2023; 19(3):768-772. PubMed ID: 37470608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Giant Cell Lesions of the Maxillofacial Skeleton Express RANKL by RNA In Situ Hybridization Regardless of Histologic Pattern.
    Stagner AM; Sajed DP; Nielsen GP; Ebb DH; Faquin WC; Chebib I; Rivera MN; Ting DT; Resnick CM; Peacock ZS; Kaban LB; Deshpande V
    Am J Surg Pathol; 2019 Jun; 43(6):819-826. PubMed ID: 30998511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study.
    Takeuchi A; Tsuchiya H; Ishii T; Nishida Y; Abe S; Matsumine A; Kawai A; Yoshimura K; Ueda T
    BMC Musculoskelet Disord; 2016 Jul; 17():306. PubMed ID: 27448567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Translational Study of the Neoplastic Cells of Giant Cell Tumor of Bone Following Neoadjuvant Denosumab.
    Mak IW; Evaniew N; Popovic S; Tozer R; Ghert M
    J Bone Joint Surg Am; 2014 Aug; 96(15):e127. PubMed ID: 25100780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy and safety of short-course neoadjuvant denosumab for en bloc spondylectomy in spinal giant cell tumor of bone: a preliminary report.
    Tang Q; Lu J; Zhu X; Song G; Wu H; Xu H; Wang A; Wang J
    Eur Spine J; 2023 Dec; 32(12):4297-4305. PubMed ID: 37318598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective cohort study of 68 sacral giant cell tumours treated with nerve-sparing surgery and evaluation on therapeutic benefits of denosumab therapy.
    Lim CY; Liu X; He F; Liang H; Yang Y; Ji T; Yang R; Guo W
    Bone Joint J; 2020 Feb; 102-B(2):177-185. PubMed ID: 32009426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Denosumab Treatment for Giant Cell Tumor of the Spine Including the Sacrum.
    Bukata SV; Blay JY; Rutkowski P; Skubitz K; Henshaw R; Seeger L; Dai T; Jandial D; Chawla S
    Spine (Phila Pa 1976); 2021 Mar; 46(5):277-284. PubMed ID: 33038190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Denosumab: a new treatment option for giant cell tumor of bone.
    Lewin J; Thomas D
    Drugs Today (Barc); 2013 Nov; 49(11):693-700. PubMed ID: 24308016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor microenvironment in giant cell tumor of bone: evaluation of PD-L1 expression and SIRPα infiltration after denosumab treatment.
    Toda Y; Kohashi K; Yamamoto H; Ishihara S; Ito Y; Susuki Y; Kawaguchi K; Kiyozawa D; Takamatsu D; Kinoshita I; Yamada Y; Maehara J; Kimura A; Tamiya S; Taguchi K; Matsunobu T; Matsumoto Y; Nakashima Y; Mawatari M; Oda Y
    Sci Rep; 2021 Jul; 11(1):14821. PubMed ID: 34285260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab.
    Palmerini E; Seeger LL; Gambarotti M; Righi A; Reichardt P; Bukata S; Blay JY; Dai T; Jandial D; Picci P
    BMC Cancer; 2021 Jan; 21(1):89. PubMed ID: 33482769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Denosumab treatment for giant-cell tumor of bone: a systematic review of the literature.
    Luengo-Alonso G; Mellado-Romero M; Shemesh S; Ramos-Pascua L; Pretell-Mazzini J
    Arch Orthop Trauma Surg; 2019 Oct; 139(10):1339-1349. PubMed ID: 30877429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.